Test
MD33 Vaccines II
Este test tiene tipos de pregunta que se abren en el reproductor de siempre.
Preguntas del test (6)
1Components of a vaccine:
• Antigen – provides [blank_start]disease specificity[blank_end]
• Adjuvant – provides [blank_start]potency[blank_end]
• [blank_start]Formulation/Delivery[blank_end] system – does everything else- Adisease specificity
- Bpotency
- CFormulation/Delivery
2Adjuvants function to:
• [blank_start]Enhance[blank_end] immune responses
• Increase [blank_start]immunogenicity[blank_end] of weak antigens
• Decrease [blank_start]amount of antigen[blank_end] required
• Modulate [blank_start]type[blank_end] of response - Th1, Th2, CD8- AEnhance
- Bimmunogenicity
- Camount of antigen
- Dtype
3Types of adjuvants –
1. Mineral salts e.g. [blank_start]alum[blank_end]
2. Bacterial products
• Bacterial [blank_start]toxins[blank_end] (de-toxified) - e.g. cholera toxin for mucosal vaccines, IgA
• Pathogen-associated molecular patterns ([blank_start]PAMP[blank_end]) e.g. MPL
3. Natural products/mediators
a. Heterologous
• [blank_start]plants/animals[blank_end] - triterpenoid glycosides (saponins, QS21)
b. Autologous
• Immune regulatory [blank_start]cytokines/chemokines[blank_end] e.g.IL-2, IL-12,IFN
-> increase ability of [blank_start]immunocompromised[blank_end] individuals to respond to vaccine
-> have systemic toxicity, short half-life, are [blank_start]expensive[blank_end]
-> can we incorporate into a delivery system?- Aalum
- Btoxins
- CPAMP
- Dplants/animals
- Ecytokines/chemokines
- Fimmunocompromised
- Gexpensive
4Delivery systems - Nanoparticles:
- Protect antigen and adjuvant, [blank_start]synchronize[blank_end] delivery
- Modify spatial and temporal [blank_start]distribution[blank_end]
Can be:
• [blank_start]Biological[blank_end] – living and dead: GE vector bacteria, viruses, VLP, bacterial ghosts
• [blank_start]Synthetic[blank_end] - Lipid based (liposomes, emulsions) or polymer based (natural & synthetic)- Asynchronize
- Bdistribution
- CBiological
- DSynthetic
5Depots can provide [blank_start]sustained[blank_end] release, can be loaded with antigen & adjuvant or nanoparticles (containing antigen & adjuvant), and can be [blank_start]stimuli[blank_end] responsive.
Types:
• Alum - non-crystalline [blank_start]gels[blank_end], safe, not suitable for stimulating cellular ([blank_start]CD8[blank_end]) responses
• Emulsions - oil & water (O/W, W/O, W/O/W) & can include [blank_start]nanoparticles[blank_end]
• Hydrogels - networks of cross linked [blank_start]polymers[blank_end] (natural eg chitosan or synthetic eg poloxamer) & can include nanoparticles.- Asustained
- Bstimuli
- Cgels
- DCD8
- Enanoparticles
- Fpolymers
6Needle-free delivery would be ideal for vaccines, but is presently only possible for pathogens that [blank_start]naturally[blank_end] infect the GIT. Barriers include:
• [blank_start]Physical[blank_end] barriers
• [blank_start]Anti-microbial[blank_end] defenses
• [blank_start]Tolerogenic[blank_end] immune processes
• Poor [blank_start]bioavailability[blank_end]- Anaturally
- BPhysical
- CAnti-microbial
- DTolerogenic
- Ebioavailability
Información
- Descripción
- (Medicines) PHCY211 Test sobre MD33 Vaccines II, creado por Mer Scott el 27/05/2018.
- Autor
- Mer Scott
- Idioma
- English
- Visitas
- 2
- Etiquetas
- Valoración
- Aún sin valoraciones Valora este test